PTPRC and Parkinson disease: Interestingly, we did not observe changes in microglial pan markers (CD45 and IBA-1), but this is consistent with what we have observed in previous studies in Parkinson’s disease where we showed a neuroprotective effect of sFKN over expression but no concomitant reduction in MHC-II expression (Nash et al. 2015).